ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
REGENXBIO Inc

REGENXBIO Inc (RGNX)

8,21
-0,23
(-2,73%)
Fermé 09 Février 10:00PM
8,57
0,36
(4,38%)
Après les heures de négociation: 1:59AM

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Statistiques et détails clés

Dernier
8,57
Prix Achat
7,95
Prix Vente
8,66
Volume échangé
563 056
8,20 Fourchette du Jour 8,66
6,56 Plage de 52 semaines 28,80
Cap du marché
Clôture Veille
8,44
Ouverture
8,55
Dernière Transaction
50
@
8.6
Dernière heure de transaction
Volume financier
US$ 4 703 071
VWAP
8,3528
Volume moyen (3 m)
1 367 430
Actions en circulation
49 545 071
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-1,54
Bénéfice par action (BPA)
-5,32
Chiffre d'affairess
90,24M
Bénéfice net
-263,49M

À propos de REGENXBIO Inc

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neur... Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno-associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). Show more

Secteur
Biological Pds,ex Diagnstics
Industrie
Biological Pds,ex Diagnstics
Siège social
Wilmington, Delaware, USA
Fondé
-
REGENXBIO Inc est coté dans le secteur Biological Pds,ex Diagnstics de la NASDAQ avec le ticker RGNX. Le dernier cours de clôture d'REGENXBIO était de US$8,44. Au cours de la dernière année, les actions de REGENXBIO ont été négociées dans une fourchette de prix de US$ 6,56 à US$ 28,80.

REGENXBIO compte actuellement 49 545 071 actions en circulation. La capitalisation boursière d'REGENXBIO est de US$418,16 million. REGENXBIO a un ratio cours/bénéfice (ratio PE) de -1.54.

RGNX Dernières nouvelles

REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025

REGENXBIO Announces Presentations of RGX-121 at the 21st Annual WORLDSymposium 2025 PR Newswire ROCKVILLE, Md., Jan. 30, 2025 ROCKVILLE, Md., Jan. 30, 2025 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq:...

REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases

REGENXBIO and Nippon Shinyaku Announce Exclusive Partnership to Develop and Commercialize RGX-121 and RGX-111 for MPS Diseases PR Newswire ROCKVILLE, Md., Jan. 14, 2025 REGENXBIO to receive $110...

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program

AbbVie and REGENXBIO Announce Updates on the ABBV-RGX-314 Clinical Program PR Newswire NORTH CHICAGO, Ill. and ROCKVILLE, Md., Jan. 13, 2025 Pivotal data evaluating the safety and efficacy of the...

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
10.627.798742138367.958.74517.518766638.16883535CS
40.577.12588.74516.5610424767.55170539CS
12-2.99-25.865051903111.5611.636.5613674308.30849955CS
26-4.54-34.630053394413.1113.486.568813399.17437797CS
52-4.94-36.565507031813.5128.86.5676450612.41691956CS
156-17.85-67.562452687426.4235.736.5652916317.28257056CS
260-41.01-82.714804356649.5854.976.5648030323.83842254CS

RGNX - Frequently Asked Questions (FAQ)

What is the current REGENXBIO share price?
The current share price of REGENXBIO is US$ 8,57
How many REGENXBIO shares are in issue?
REGENXBIO has 49 545 071 shares in issue
What is the market cap of REGENXBIO?
The market capitalisation of REGENXBIO is USD 418,16M
What is the 1 year trading range for REGENXBIO share price?
REGENXBIO has traded in the range of US$ 6,56 to US$ 28,80 during the past year
What is the PE ratio of REGENXBIO?
The price to earnings ratio of REGENXBIO is -1,54
What is the cash to sales ratio of REGENXBIO?
The cash to sales ratio of REGENXBIO is 4,51
What is the reporting currency for REGENXBIO?
REGENXBIO reports financial results in USD
What is the latest annual turnover for REGENXBIO?
The latest annual turnover of REGENXBIO is USD 90,24M
What is the latest annual profit for REGENXBIO?
The latest annual profit of REGENXBIO is USD -263,49M
What is the registered address of REGENXBIO?
The registered address for REGENXBIO is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the REGENXBIO website address?
The website address for REGENXBIO is www.regenxbio.com
Which industry sector does REGENXBIO operate in?
REGENXBIO operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
780,46M
CDTConduit Pharmaceuticals Inc
US$ 2,831
(82,65%)
140,32M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
215,16M
TOIIWOncology Institute Inc
US$ 0,033
(58,88%)
7,27k
CYTHCyclo Therapeutics Inc
US$ 1,19
(54,55%)
72,39M
FTELFitell Corporation
US$ 2,70
(-57,01%)
2,3M
SGBXSafe and Green Holdings Corporation
US$ 0,6401
(-44,82%)
5,65M
NKLANikola Corporation
US$ 0,4432
(-41,10%)
52,44M
PLRXPliant Therapeutics Inc
US$ 7,785
(-34,85%)
6,44M
LIPOLipella Pharmaceuticals Inc
US$ 3,08
(-33,76%)
2,2M
MGOLMGO Global Inc
US$ 0,4191
(126,54%)
816,59M
RIMEAlgorhythm Holdings Inc
US$ 0,0169
(-20,66%)
274,2M
NVDANVIDIA Corporation
US$ 129,84
(0,90%)
228,2M
GSIWGarden Stage Ltd
US$ 0,79
(78,73%)
219,64M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0537
(14,74%)
212,29M
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock